UPK2 and urinary bladder carcinoma: Further, transgenic mice with continuous activation of HRAS gene developed non-invasive bladder cancer, whereas transgenic mice with UPII promoter-SV40T gene in combination with persistent inactivation of p53 and pRb gene developed invasive bladder cancer [15].